Kala Bio Inc (KALA)
6.60
-0.13
(-1.93%)
USD |
NASDAQ |
May 20, 16:00
6.60
0.00 (0.00%)
After-Hours: 20:00
Kala Bio Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2022 | -1.34K% |
| March 31, 2022 | -2.40K% |
| December 31, 2021 | -2.56K% |
| September 30, 2021 | -917.1% |
| June 30, 2021 | -1.20K% |
| March 31, 2021 | -931.2% |
| December 31, 2020 | -1.39K% |
| Date | Value |
|---|---|
| September 30, 2020 | -1.26K% |
| June 30, 2020 | -2.80K% |
| March 31, 2020 | -2.05K% |
| December 31, 2019 | -1.86K% |
| September 30, 2019 | -1.60K% |
| June 30, 2019 | -1.16K% |
| March 31, 2019 | -1.83K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-2.80K%
Minimum
Jun 2020
-917.1%
Maximum
Sep 2021
-1.65K%
Average
-1.39K%
Median
Dec 2020
Profit Margin (Quarterly) Benchmarks
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | -14.54K% |
| IGC Pharma Inc | -2.74K% |
| NovaBay Pharmaceuticals Inc | -122.2% |
| Protalix BioTherapeutics Inc | -122.6% |